دورية أكاديمية
أعرض في EDS

Navigating glioblastoma complexity: the interplay of neurotransmitters and chromatin.

التفاصيل البيبلوغرافية
العنوان: Navigating glioblastoma complexity: the interplay of neurotransmitters and chromatin.
المؤلفون: Romero-Reyes J; Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, México., Vázquez-Martínez ER; Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, México., Silva CC; Chronobiology of Reproduction Research Lab. Biology of Reproduction Research Unit, Carrera de Biología, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México, Mexico City, México., Molina-Hernández A; Departamento de Fisiología y Desarrollo Celular, Instituto Nacional de Perinatología, Mexico City, México., Díaz NF; Departamento de Fisiología y Desarrollo Celular, Instituto Nacional de Perinatología, Mexico City, México. nfdiaz00@yahoo.com.mx., Camacho-Arroyo I; Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, México. camachoarroyo@gmail.com.
المصدر: Molecular biology reports [Mol Biol Rep] 2024 Aug 17; Vol. 51 (1), pp. 912. Date of Electronic Publication: 2024 Aug 17.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Dordrecht, Boston, Reidel.
مواضيع طبية MeSH: Glioblastoma*/metabolism , Glioblastoma*/genetics , Glioblastoma*/pathology , Neurotransmitter Agents*/metabolism , Chromatin*/metabolism , Brain Neoplasms*/metabolism , Brain Neoplasms*/genetics , Brain Neoplasms*/pathology , Neoplastic Stem Cells*/metabolism , Neoplastic Stem Cells*/pathology , Tumor Microenvironment*/genetics, Humans ; Epigenesis, Genetic ; Dopamine/metabolism ; Animals ; Serotonin/metabolism ; Gene Expression Regulation, Neoplastic
مستخلص: Glioblastoma is the most aggressive brain cancer with an unfavorable prognosis for patient survival. Glioma stem cells, a subpopulation of cancer cells, drive tumor initiation, self-renewal, and resistance to therapy and, together with the microenvironment, play a crucial role in glioblastoma maintenance and progression. Neurotransmitters such as noradrenaline, dopamine, and serotonin have contrasting effects on glioblastoma development, stimulating or inhibiting its progression depending on the cellular context and through their action on glioma stem cells, perhaps changing the epigenetic landscape. Recent studies have revealed that serotonin and dopamine induce chromatin modifications related to transcriptional plasticity in the mammalian brain and possibly in glioblastoma; however, this topic still needs to be explored because of its potential implications for glioblastoma treatment. Also, it is essential to consider that neurotransmitters' effects depend on the tumor's microenvironment since it can significantly influence the response and behavior of cancer cells. This review examines the possible role of neurotransmitters as regulators of glioblastoma development, focusing on their impact on the chromatin of glioma stem cells.
(© 2024. The Author(s).)
References: Anal Chem. 2023 Apr 11;95(14):5994-6001. (PMID: 36995369)
J Physiol. 2016 Feb 15;594(4):863-81. (PMID: 26574176)
Proc Natl Acad Sci U S A. 1972 Jul;69(7):1677-80. (PMID: 4340154)
Int J Biol Sci. 2020 May 18;16(12):2104-2115. (PMID: 32549758)
Trends Cancer. 2015 Dec;1(4):252-265. (PMID: 27088132)
Brain Res. 2021 Apr 1;1756:147280. (PMID: 33515535)
BMC Cancer. 2022 Apr 26;22(1):457. (PMID: 35473609)
Front Oncol. 2021 Jan 29;10:603495. (PMID: 33585220)
Nature. 2006 Dec 7;444(7120):756-60. (PMID: 17051156)
Nat Commun. 2024 May 30;15(1):4616. (PMID: 38816355)
Nat Commun. 2022 Jan 10;13(1):116. (PMID: 35013227)
Nat Commun. 2020 Jul 8;11(1):3406. (PMID: 32641768)
Nat Commun. 2022 Aug 15;13(1):4767. (PMID: 35970913)
Nat Chem Biol. 2007 May;3(5):268-73. (PMID: 17417631)
Commun Biol. 2022 Jun 16;5(1):593. (PMID: 35710828)
Cancer Cell. 2010 Jan 19;17(1):98-110. (PMID: 20129251)
Neoplasia. 2023 May;39:100894. (PMID: 36972629)
Cell Death Dis. 2019 Nov 21;10(12):877. (PMID: 31754093)
Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):346-354. (PMID: 29684521)
Sci Transl Med. 2019 Jan 2;11(473):. (PMID: 30602536)
Nature. 2019 Mar;567(7749):535-539. (PMID: 30867594)
Sci Transl Med. 2020 Feb 26;12(532):. (PMID: 32102932)
Cells. 2021 Jul 14;10(7):. (PMID: 34359952)
Epigenetics Chromatin. 2013 Oct 16;6(1):34. (PMID: 24279307)
Nat Rev Genet. 2022 Sep;23(9):563-580. (PMID: 35338361)
J Neurosci. 2019 Mar 13;39(11):1982-1993. (PMID: 30651332)
Oncogene. 2021 Mar;40(11):2065-2080. (PMID: 33627784)
Nat Rev Cancer. 2020 Jan;20(1):57-70. (PMID: 31806884)
Nature. 2010 Dec 9;468(7325):829-33. (PMID: 21102433)
BMC Cancer. 2022 Feb 26;22(1):213. (PMID: 35219305)
Nat Commun. 2022 Apr 25;13(1):2236. (PMID: 35469026)
Lancet. 2020 Aug 22;396(10250):565-582. (PMID: 32828189)
Dev Cell. 2023 Jan 23;58(2):81-93. (PMID: 36693322)
Nature. 2010 Dec 9;468(7325):824-8. (PMID: 21102434)
Nat Clin Pract Neurol. 2008 Aug;4(8):427-35. (PMID: 18628751)
Int J Oncol. 2018 Apr;52(4):1235-1245. (PMID: 29532867)
iScience. 2022 Aug 04;25(9):104872. (PMID: 36034219)
Nihon Ika Daigaku Zasshi. 1984 Feb;51(1):132-3. (PMID: 6725540)
Nature. 2019 Sep;573(7775):539-545. (PMID: 31534222)
Life Sci. 2020 May 15;249:117536. (PMID: 32165211)
Cell Death Dis. 2021 Mar 24;12(4):312. (PMID: 33762574)
Sci Rep. 2018 Oct 8;8(1):14965. (PMID: 30297697)
Arch Med Res. 2022 Dec;53(8):840-858. (PMID: 36470770)
Dev Cell. 2022 Jan 10;57(1):32-46.e8. (PMID: 35016005)
Nat Genet. 2022 Dec;54(12):1881-1894. (PMID: 36471067)
Proc Natl Acad Sci U S A. 2022 Oct 25;119(43):e2208672119. (PMID: 36256821)
Trends Genet. 2022 Mar;38(3):273-289. (PMID: 34702577)
Trends Biochem Sci. 2020 Oct;45(10):829-844. (PMID: 32498971)
J Neurochem. 2005 Jan;92(2):311-20. (PMID: 15663479)
Nature. 2023 May;617(7961):599-607. (PMID: 37138086)
Genes (Basel). 2022 Dec 15;13(12):. (PMID: 36553636)
Cell Stem Cell. 2017 Feb 2;20(2):233-246.e7. (PMID: 27989769)
Cell Rep. 2017 Oct 24;21(4):943-952. (PMID: 29069602)
Cell Rep. 2021 Nov 2;37(5):109957. (PMID: 34731610)
Nat Commun. 2021 Oct 21;12(1):6130. (PMID: 34675201)
Nucleic Acids Res. 2020 Sep 18;48(16):8993-9006. (PMID: 32710624)
Cell Death Differ. 2022 Jul;29(7):1379-1394. (PMID: 35058574)
J Biol Chem. 2000 Mar 31;275(13):9390-5. (PMID: 10734083)
J Cancer Res Clin Oncol. 2021 Oct;147(10):2969-2982. (PMID: 34170383)
J Mol Biol. 2021 Mar 19;433(6):166678. (PMID: 33065110)
Sci Rep. 2016 Mar 18;6:23372. (PMID: 26988603)
Nat Chem Biol. 2021 Apr;17(4):403-411. (PMID: 33649601)
Int J Oncol. 2010 Oct;37(4):1043-51. (PMID: 20811727)
Science. 2020 Apr 10;368(6487):197-201. (PMID: 32273471)
Nat Commun. 2021 Jun 15;12(1):3621. (PMID: 34131149)
J Med Chem. 2022 Sep 22;65(18):12124-12139. (PMID: 36098685)
Oncogene. 2009 Nov 12;28(45):3949-59. (PMID: 19718046)
Neurosci Res. 2008 Jan;60(1):40-9. (PMID: 17980449)
Proc Natl Acad Sci U S A. 2020 May 19;117(20):11085-11096. (PMID: 32358191)
Nat Commun. 2020 Dec 18;11(1):6434. (PMID: 33339831)
Sci Adv. 2022 Aug 5;8(31):eabn3986. (PMID: 35921410)
فهرسة مساهمة: Keywords: Glioblastoma; Glioma stem cells; Neurotransmitters; Post-translational modifications; Serotonylation
المشرفين على المادة: 0 (Neurotransmitter Agents)
0 (Chromatin)
VTD58H1Z2X (Dopamine)
333DO1RDJY (Serotonin)
تواريخ الأحداث: Date Created: 20240817 Date Completed: 20240817 Latest Revision: 20240820
رمز التحديث: 20240820
مُعرف محوري في PubMed: PMC11330389
DOI: 10.1007/s11033-024-09853-3
PMID: 39153092
قاعدة البيانات: MEDLINE
الوصف
تدمد:1573-4978
DOI:10.1007/s11033-024-09853-3